Dopaminergic Mechanisms and Luteinizing Hormone Secretion. I. Acute Administration of the Dopamine Agonist Bromocriptine Does Not Inhibit Luteinizing Hormone Release in Hyperprolactinemic Women* [PDF]
William S. Evans +3 more
openalex +1 more source
Bromocriptine and the Clinical Spectrum of Parkinson's Disease [PDF]
Richard J. Riopelle
openalex +1 more source
Idiopathic hyperprolactinemia-associated hypogonadism in men presenting with normal testosterone levels. [PDF]
Cheng X +6 more
europepmc +1 more source
Dopaminergic drugs modulate fear extinction-related processes in humans, but effects are mild. [PDF]
Doubliez A +13 more
europepmc +1 more source
Effectiveness of bromocriptine treatment in a patient with peripartum cardiomyopathy [PDF]
Masaru Ichida +8 more
openalex +1 more source
Dopamine enhances surface glial glycolysis via acetylcholine and insulin/insulin-like growth factor signaling in the honeybee. [PDF]
Zhang M +9 more
europepmc +1 more source
Correction: Evaluation of Efficacy of Bromocriptine as a Therapeutic Modality in the Treatment of Diabetes Mellitus: A Systematic Review. [PDF]
Patel P +10 more
europepmc +1 more source
Effect of bromocriptine on plasma growth hormone and glucose tolerance in chronic renal failure. [PDF]
J. A. Kanis +4 more
openalex +1 more source
LACK OF BROMOCRIPTINE-INDUCED REDUCTION OF GROWTH PREDICTION IN TALL ADOLESCENTS [PDF]
Ε. Schoenle +5 more
openalex +1 more source

